Literature DB >> 8253787

A molecular mechanism for autoinhibition of myosin light chain kinases.

P J Gallagher1, B P Herring, A Trafny, J Sowadski, J T Stull.   

Abstract

It is postulated that basic residues within the inhibitory region of myosin light chain kinase (MLCK) bind acidic residues within the catalytic core to maintain the kinase in an inactive form. In this study, we identified residues within the catalytic cores of the skeletal and smooth muscle MLCKs that may bind basic residues in inhibitory region. Acidic residues within the catalytic core of the rabbit skeletal and smooth muscle MLCKs were mutated and the kinetic properties of the mutant kinases determined. Mutation of 6 and 8 acidic residues in the skeletal and smooth muscle MLCKs, respectively, result in mutant MLCKs with decreases in KCaM (the concentration of calmodulin required for half-maximal activation of myosin light chain kinase) value ranging from 2- to 100-fold. Two inhibitory domain binding residues identified in each kinase also bind a basic residue in light chain substrate. The remaining mutants all have wild-type Km values for light chain. The predicted inhibitory domain binding residues are distributed in a linear fashion across the surface of the lower lobe of the proposed molecular model of the smooth muscle MLCK catalytic core. As 6 of the inhibitory domain binding residues in the smooth muscle MLCK are conserved in other Ca2+/calmodulin-dependent protein kinases, the structural basis for autoinhibition and activation may be similar.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253787      PMCID: PMC2836759     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Substrate specificity of myosin light chain kinases.

Authors:  B P Herring; P J Gallagher; J T Stull
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  A novel Ca2+/calmodulin-dependent protein kinase and a male germ cell-specific calmodulin-binding protein are derived from the same gene.

Authors:  A R Means; F Cruzalegui; B LeMagueresse; D S Needleman; G R Slaughter; T Ono
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Molecular characterization of a mammalian smooth muscle myosin light chain kinase.

Authors:  P J Gallagher; B P Herring; S A Griffin; J T Stull
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

4.  Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.

Authors:  C J Foster; S A Johnston; B Sunday; F C Gaeta
Journal:  Arch Biochem Biophys       Date:  1990-08-01       Impact factor: 4.013

5.  Myosin light chain kinase phosphorylation in tracheal smooth muscle.

Authors:  J T Stull; L C Hsu; M G Tansey; K E Kamm
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

6.  Acidic residues comprise part of the myosin light chain-binding site on skeletal muscle myosin light chain kinase.

Authors:  B P Herring; D P Fitzsimons; J T Stull; P J Gallagher
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

7.  Effects of pH, ionic strength, and temperature on activation by calmodulin an catalytic activity of myosin light chain kinase.

Authors:  D K Blumenthal; J T Stull
Journal:  Biochemistry       Date:  1982-05-11       Impact factor: 3.162

8.  Selective purification of the 20,000-Da light chains of smooth muscle myosin.

Authors:  D R Hathaway; J R Haeberle
Journal:  Anal Biochem       Date:  1983-11       Impact factor: 3.365

9.  Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor.

Authors:  J Zheng; D R Knighton; L F ten Eyck; R Karlsson; N Xuong; S S Taylor; J M Sowadski
Journal:  Biochemistry       Date:  1993-03-09       Impact factor: 3.162

Review 10.  Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function.

Authors:  H L Sweeney; B F Bowman; J T Stull
Journal:  Am J Physiol       Date:  1993-05
View more
  19 in total

Review 1.  Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II.

Authors:  Andy Hudmon; Howard Schulman
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction.

Authors:  John Kolega
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

3.  A genetic strategy for the dynamic and graded control of cell mechanics, motility, and matrix remodeling.

Authors:  Joanna L MacKay; Albert J Keung; Sanjay Kumar
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

Review 4.  Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle.

Authors:  James T Stull; Kristine E Kamm; Rene Vandenboom
Journal:  Arch Biochem Biophys       Date:  2011-02-01       Impact factor: 4.013

Review 5.  Myosin light chain kinases.

Authors:  P J Gallagher; B P Herring; J T Stull
Journal:  J Muscle Res Cell Motil       Date:  1997-02       Impact factor: 2.698

Review 6.  Biochemistry of smooth muscle myosin light chain kinase.

Authors:  Feng Hong; Brian D Haldeman; Del Jackson; Mike Carter; Jonathan E Baker; Christine R Cremo
Journal:  Arch Biochem Biophys       Date:  2011-05-03       Impact factor: 4.013

7.  Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and -independent kinase activities.

Authors:  Audrey N Chang; Pravin Mahajan; Stefan Knapp; Hannah Barton; H Lee Sweeney; Kristine E Kamm; James T Stull
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

Review 8.  Role of myosin light chain phosphatase in cardiac physiology and pathophysiology.

Authors:  Audrey N Chang; Kristine E Kamm; James T Stull
Journal:  J Mol Cell Cardiol       Date:  2016-10-11       Impact factor: 5.000

9.  Identification of a new form of death-associated protein kinase that promotes cell survival.

Authors:  Y Jin; E K Blue; S Dixon; L Hou; R B Wysolmerski; P J Gallagher
Journal:  J Biol Chem       Date:  2001-08-02       Impact factor: 5.157

Review 10.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.